Suppr超能文献

慢性完全闭塞经皮冠状动脉介入治疗围手术期风险预测评分的系统评价

A Systematic Review of Periprocedural Risk Prediction Scores in Chronic Total Occlusion Percutaneous Coronary Intervention.

机构信息

Center for Coronary Artery Disease, Minneapolis Heart Institute and Minneapolis Heart Institute Foundation, Minneapolis, Minnesota.

School of Medicine, Pramukhswami Medical College, Karamsad, Gujarat, India.

出版信息

Am J Cardiol. 2023 Apr 15;193:118-125. doi: 10.1016/j.amjcard.2023.01.044. Epub 2023 Mar 9.

Abstract

Chronic total occlusion (CTO) percutaneous coronary intervention (PCI) is associated with high incidence of complications. We queried PubMed and the Cochrane Library (last search: October 26, 2022) for CTO PCI-specific periprocedural complication risk scores. We identified 8 CTO PCI-specific risk scores: (1) Angiographic coronary artery perforation (OPEN-CLEAN [Outcomes, Patient Health Status, and Efficiency iN (OPEN) Chronic Total Occlusion (CTO) Hybrid Procedures - CABG, Length (occlusion), EF <50%, Age, CalcificatioN] perforation, c-statistic 0.75): previous coronary artery bypass graft surgery, occlusion length 20 to 60 mm or ≥60 mm, left ventricular ejection fraction (LVEF) <50%, age 50 to 70 years or ≥70 years, heavy calcification. (2) Major adverse cardiovascular events (MACE) (PROGRESS-CTO complication, c-statistic 0.76): age >65 years, lesion length ≥23 mm, retrograde strategy, and (3) MACE (PROGRESS-CTO MACE, c-statistic 0.74): age ≥65 years, female gender, moderate/severe calcification, blunt/no stump, anterograde dissection and re-entry (ADR) or retrograde strategy. (4) All-cause mortality (PROGRESS-CTO mortality, c-statistic 0.80): age ≥65, moderate/severe calcification, LVEF ≤45%, ADR or retrograde strategy. (5) Perforation requiring pericardiocentesis (PROGRESS-CTO pericardiocentesis, c-statistic 0.78): age ≥65 years, moderate/severe calcification, female gender, ADR or retrograde strategy. (6) Acute myocardial infarction (PROGRESS-CTO acute myocardial infarction, c-statistic 0.72): previous coronary artery bypass graft surgery, atrial fibrillation, blunt/no stump. (7) Perforation requiring any treatment (PROGRESS-CTO perforation, c-statistic 0.74): age ≥65 years, moderate/severe calcification, blunt/no stump, ADR, or retrograde strategy. (8) Contrast-induced acute kidney injury (c-statistic 0.84): age ≥75, LVEF <40%, serum creatinine >1.5 mg/100 ml, serum albumin ≤30, 30<albumin≤40 or >40 g/L. There are 8 CTO PCI periprocedural risk scores that may facilitate risk assessment and procedural planning in patients who underwent CTO PCI.

摘要

慢性完全闭塞(CTO)经皮冠状动脉介入治疗(PCI)与高并发症发生率相关。我们在 PubMed 和 Cochrane Library 中查询了 CTO PCI 特定围手术期并发症风险评分(最后一次搜索日期:2022 年 10 月 26 日)。我们确定了 8 个 CTO PCI 特定风险评分:(1)血管造影冠状动脉穿孔(OPEN-CLEAN [结果、患者健康状况和效率 iN(OPEN)慢性完全闭塞(CTO)杂交手术-冠状动脉旁路移植术、长度(闭塞)、EF <50%、年龄、钙化 N]穿孔,C 统计量 0.75):先前的冠状动脉旁路移植术、闭塞长度 20 至 60mm 或 ≥60mm、左心室射血分数(LVEF)<50%、年龄 50 至 70 岁或≥70 岁、重度钙化。(2)主要不良心血管事件(MACE)(PROGRESS-CTO 并发症,C 统计量 0.76):年龄>65 岁、病变长度≥23mm、逆行策略,和(3)MACE(PROGRESS-CTO MACE,C 统计量 0.74):年龄≥65 岁,女性,中度/重度钙化,钝/无残端,顺行夹层和再进入(ADR)或逆行策略。(4)全因死亡率(PROGRESS-CTO 死亡率,C 统计量 0.80):年龄≥65 岁,中度/重度钙化,LVEF≤45%,ADR 或逆行策略。(5)需要心包穿刺的穿孔(PROGRESS-CTO 心包穿刺,C 统计量 0.78):年龄≥65 岁,中度/重度钙化,女性,ADR 或逆行策略。(6)急性心肌梗死(PROGRESS-CTO 急性心肌梗死,C 统计量 0.72):先前的冠状动脉旁路移植术、心房颤动、钝/无残端。(7)需要任何治疗的穿孔(PROGRESS-CTO 穿孔,C 统计量 0.74):年龄≥65 岁,中度/重度钙化,钝/无残端,ADR 或逆行策略。(8)对比剂诱导的急性肾损伤(C 统计量 0.84):年龄≥75 岁,LVEF<40%,血清肌酐>1.5mg/100ml,血清白蛋白≤30,30<白蛋白≤40 或>40g/L。有 8 个 CTO PCI 围手术期风险评分,可在接受 CTO PCI 的患者中进行风险评估和手术计划。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验